These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37814274)

  • 1. Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report.
    Li Y; Zhou Q
    BMC Ophthalmol; 2023 Oct; 23(1):405. PubMed ID: 37814274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid resolution of severe exudation in uveal effusion syndrome with anti-vascular endothelial growth factor alone in a case of bilateral nanophthalmos: a case report.
    Song L; Dong F; Yi C
    J Med Case Rep; 2021 Oct; 15(1):515. PubMed ID: 34663453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of uveal effusion syndrome.
    Lee JH; Choi JY; Kim SS
    Korean J Ophthalmol; 2006 Jun; 20(2):124-7. PubMed ID: 16892650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Nanophthalmos Presenting with Spontaneous Uveal Effusion Syndrome.
    Bansal R; Menia NK; Gupta A
    Ocul Immunol Inflamm; 2020; 28(2):191-193. PubMed ID: 30556758
    [No Abstract]   [Full Text] [Related]  

  • 5. Uveal effusion syndrome: a case report.
    Hodges B; Omoruyi F; Allison K
    J Med Case Rep; 2024 Mar; 18(1):169. PubMed ID: 38509616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanophthalmos with longstanding choroidal effusion and serous retinal detachment.
    Han L; Cairns JD
    Aust N Z J Ophthalmol; 1997 May; 25(2):181-3. PubMed ID: 9267610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choroidal effusion following laser peripheral iridotomy for the treatment of angle closure glaucoma in a patient with nanophthalmos.
    Thapa SS; Paudyal G
    Nepal Med Coll J; 2005 Jun; 7(1):81-2. PubMed ID: 16295732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual non-nanophthalmic uveal effusion syndrome with histologically normal scleral architecture: a case report.
    Kaewsangthong K; Thoongsuwan S; Uiprasertkul M; Phasukkijwatana N
    BMC Ophthalmol; 2020 Jul; 20(1):311. PubMed ID: 32727414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleral window surgery and topical mitomycin C for nanophthalmic uveal effusion complicated by renal failure: case report.
    Suzuki Y; Nishina S; Azuma N
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):755-7. PubMed ID: 17024441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vortex vein decompression for nanophthalmic uveal effusion.
    Brockhurst RJ
    Arch Ophthalmol; 1980 Nov; 98(11):1987-90. PubMed ID: 7436831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual rapid resolution of postsclerectomy exudative retinal detachment with topical NSAIDs therapy in a case of nanophthalmos.
    Tong B; Wang C; Qi X
    J Int Med Res; 2020 Aug; 48(8):300060519847376. PubMed ID: 31081412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report.
    Onoe H; Shimada H; Kawamura A; Hirosawa H; Tanaka K; Mori R; Nakashizuka H
    BMC Ophthalmol; 2022 Feb; 22(1):91. PubMed ID: 35197001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotomy in uveal effusion syndrome.
    Faulborn J; Kölli H
    Retina; 1999; 19(6):504-7. PubMed ID: 10606449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quadrantic vortex vein decompression with subretinal fluid drainage for manangement of Nanophthalmic choroidal effusions- a review of literature and case series.
    Khatri A; Singh S; Joshi K; Kharel M
    BMC Ophthalmol; 2019 Oct; 19(1):210. PubMed ID: 31651283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uveal effusion syndrome in nanophthalmic eye after trabeculectomy].
    Bluwol E; Nordmann JP
    J Fr Ophtalmol; 2007 May; 30(5):e13. PubMed ID: 17568336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanophthalmos with uveal effusion. A new clinical entity.
    Brockhurst RJ
    Arch Ophthalmol; 1975 Dec; 93(12):1989-99. PubMed ID: 1200903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
    Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
    Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVEAL EFFUSION SYNDROME. CASE REPORT.
    Konrád A; Penčák M; Veith M; Studený P
    Cesk Slov Oftalmol; 2021; 77(4):202-206. PubMed ID: 34507496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Nanophthalmos-Related Uveal Effusion with Two- vs. Four-Quadrant Partial-Thickness Sclerectomy and Sclerotomy Surgery.
    Özdek Ş; Yalınbaş Yeter D; Özmen MC; Hasanreisoğlu M
    Turk J Ophthalmol; 2022 Feb; 52(1):37-44. PubMed ID: 35196838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanophthalmos with uveal effusion: clinical and embryologic considerations.
    Ryan EA; Zwaan J; Chylack LT
    Ophthalmology; 1982 Sep; 89(9):1013-7. PubMed ID: 7177566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.